Piper Sandler analyst David Amsellem lowered the firm’s price target on Amphastar (AMPH) to $32 from $36 and keeps a Neutral rating on the shares. Though the firm could envision becoming more constructive to the extent that it sees key generic pipeline opportunities bear fruit, Piper nonetheless “cannot gloss over competitive challenges that are likely to pressure the top-line/EBITDA this year.”
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
- Make smarter investment decisions with TipRanks' Smart Investor Picks, delivered to your inbox every week.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on AMPH: